被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Singapore: HSA Alert: Coco Curv & Choco Fit found to contain banned substance; Hamer Candy detected with potent ingredient similar to erectile dysfunction medicine (English only) |
| |
The Health Sciences Authority (HSA) is alerting members of the public not to purchase or consume three products which were sold online. HSA’s analysis of the products revealed that, contrary to the listing of ingredients on the packaging, these products contained potent ingredients including a banned substance, sibutramine, that may pose serious health risks to consumers. The three products are:
- Coco Curv: contains sibutramine (banned in Singapore)
- Choco Fit: contains sibutramine (banned in Singapore)
- Hamer Candy: contains nortadalafil (chemically related to tadalafil, an erectile dysfunction medicine)
A female consumer who purchased Coco Curv in Malaysia suspected that the product could be harmful and reported it to HSA. Coco Curv was also marketed online as a slimming product with claims such as “burn fat and calories”, “boost energy and metabolism” and “control carbohydrate craving”. During investigations into Coco Curv, HSA came across Choco Fit, another product that was sold online and marketed for slimming. HSA tested both products and detected sibutramine, which has been banned in Singapore since 2010 due to an increased risk of heart attacks and strokes, in both products.
A male consumer reported the sale of Hamer Candy as he noted that the product was previously detected to contain a potent ingredient. Hamer Candy was packaged as a candy, but HSA tested it to contain nortadalafil, which is chemically related to tadalafil, a prescription medicine used to treat male erectile dysfunction. Use of nortadalafil may lead to increased risk of serious adverse effects including low blood pressure, strokes and heart attacks.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/press-release/hsa-alert-cococurv-chocofit-hamercandy
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by HSA, and was posted on the Drug Office website on 3 Jun 2019.
Ends/Friday, Aug 7, 2020
Issued at HKT 15:00
|
| |
|
